Medication Description: Leucogenum
LEUKOGEN (Leucogenum). 2- (a-Phenyl-a-carbethoxymethyl) -thiazolidine-4-carboxylic acid.
White or white with a slightly yellowish tinge crystalline powder with a slight peculiar smell. It is practically insoluble in water, very slightly soluble in alcohol, soluble in alkali solutions. Aqueous solutions are unstable, hydrolyzed to form l-cysteine and formyl phenylacetic ester.
Used as a stimulator of leukopoesis in leukopenia caused by X-ray and radiotherapy, chemotherapy of malignant tumors, agranulocytic angina, alimentary-toxic aleukia and other diseases involving leukopenia.
Assign inside adults to 0.02 g 3 - 4 times a day. The duration of treatment depends on the nature and course of the disease.
The daily dose for children under the age of 6 months is 0.01 g, from 6 months to 1 year 0.02 g, up to 7 years - 0.04 g, older than 7 years - 0.06 g
Contraindicated in lymphogranulomatosis and malignant diseases of the blood.
Method of issuance: powder; tablets of 0.02 g
Storage: List B.